EXPLAINER: New drug slows Alzheimer's but comes with caveats
A new Alzheimer’s drug is hitting the market — the first with clear-cut evidence that it can slow, by several months, the mind-robbing disease.
Source: wtop.com
Stay updated with breaking news from Sam Gandy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A new Alzheimer’s drug is hitting the market — the first with clear-cut evidence that it can slow, by several months, the mind-robbing disease.
Here are some things to know about the FDA's approval of lecanemab, to be sold under the brand name Leqembi.
Here are some things to know about the FDA's approval of lecanemab, to be sold under the brand name Leqembi.
Here are some things to know about the FDA's approval of lecanemab, to be sold under the brand name Leqembi.
Here are some things to know about the FDA's approval of lecanemab, to be sold under the brand name Leqembi.